These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309 [TBL] [Abstract][Full Text] [Related]
44. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study. De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747 [TBL] [Abstract][Full Text] [Related]
45. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098 [TBL] [Abstract][Full Text] [Related]
46. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Cerfolio RJ; Bryant AS; Eloubeidi MA Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998 [TBL] [Abstract][Full Text] [Related]
47. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058 [TBL] [Abstract][Full Text] [Related]
48. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441 [TBL] [Abstract][Full Text] [Related]
49. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers]. Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377 [TBL] [Abstract][Full Text] [Related]
50. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Bogaert J; Maes A; Deneffe GJ; Nackaerts KL; Verschakelen JA; Lerut TE; Mortelmans LA; Demedts MG J Clin Oncol; 1998 Jun; 16(6):2142-9. PubMed ID: 9626214 [TBL] [Abstract][Full Text] [Related]
52. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074 [TBL] [Abstract][Full Text] [Related]
53. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. Lee JD; Ginsberg RJ Ann Thorac Surg; 1996 Aug; 62(2):338-41. PubMed ID: 8694587 [TBL] [Abstract][Full Text] [Related]
54. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)]. Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978 [TBL] [Abstract][Full Text] [Related]
55. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography. Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616 [TBL] [Abstract][Full Text] [Related]
56. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer. Tasci E; Tezel C; Orki A; Akin O; Falay O; Kutlu CA Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):200-3. PubMed ID: 19933240 [TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198 [TBL] [Abstract][Full Text] [Related]
58. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer. Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V Clin Lung Cancer; 2008 Jan; 9(1):39-43. PubMed ID: 18282357 [TBL] [Abstract][Full Text] [Related]